MSH2 is the very young onset ovarian cancer predisposition gene, not BRCA1

Detalles Bibliográficos
Autores principales: Flaum, Nicola, Crosbie, Emma J, Woodward, Emma Roisin, Lalloo, Fiona, Morgan, Robert, Ryan, Neil, Evans, D Gareth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Cancer Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313943/
https://www.ncbi.nlm.nih.gov/pubmed/36894311
http://dx.doi.org/10.1136/jmg-2022-109055
_version_ 1785067214333804544
author Flaum, Nicola
Crosbie, Emma J
Woodward, Emma Roisin
Lalloo, Fiona
Morgan, Robert
Ryan, Neil
Evans, D Gareth
author_facet Flaum, Nicola
Crosbie, Emma J
Woodward, Emma Roisin
Lalloo, Fiona
Morgan, Robert
Ryan, Neil
Evans, D Gareth
author_sort Flaum, Nicola
collection PubMed
description
format Online
Article
Text
id pubmed-10313943
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-103139432023-07-02 MSH2 is the very young onset ovarian cancer predisposition gene, not BRCA1 Flaum, Nicola Crosbie, Emma J Woodward, Emma Roisin Lalloo, Fiona Morgan, Robert Ryan, Neil Evans, D Gareth J Med Genet Cancer Genetics BMJ Publishing Group 2023-06 2023-03-09 /pmc/articles/PMC10313943/ /pubmed/36894311 http://dx.doi.org/10.1136/jmg-2022-109055 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Cancer Genetics
Flaum, Nicola
Crosbie, Emma J
Woodward, Emma Roisin
Lalloo, Fiona
Morgan, Robert
Ryan, Neil
Evans, D Gareth
MSH2 is the very young onset ovarian cancer predisposition gene, not BRCA1
title MSH2 is the very young onset ovarian cancer predisposition gene, not BRCA1
title_full MSH2 is the very young onset ovarian cancer predisposition gene, not BRCA1
title_fullStr MSH2 is the very young onset ovarian cancer predisposition gene, not BRCA1
title_full_unstemmed MSH2 is the very young onset ovarian cancer predisposition gene, not BRCA1
title_short MSH2 is the very young onset ovarian cancer predisposition gene, not BRCA1
title_sort msh2 is the very young onset ovarian cancer predisposition gene, not brca1
topic Cancer Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313943/
https://www.ncbi.nlm.nih.gov/pubmed/36894311
http://dx.doi.org/10.1136/jmg-2022-109055
work_keys_str_mv AT flaumnicola msh2istheveryyoungonsetovariancancerpredispositiongenenotbrca1
AT crosbieemmaj msh2istheveryyoungonsetovariancancerpredispositiongenenotbrca1
AT woodwardemmaroisin msh2istheveryyoungonsetovariancancerpredispositiongenenotbrca1
AT lalloofiona msh2istheveryyoungonsetovariancancerpredispositiongenenotbrca1
AT morganrobert msh2istheveryyoungonsetovariancancerpredispositiongenenotbrca1
AT ryanneil msh2istheveryyoungonsetovariancancerpredispositiongenenotbrca1
AT evansdgareth msh2istheveryyoungonsetovariancancerpredispositiongenenotbrca1

Ejemplares similares